Navigation Links
AHRQ Releases Toolkits to Help Providers and Patients Implement Safer Health Care Practices
Date:12/5/2007

patient risk factors frequently responsible for inaccurate medication reconciliation, including limited English proficiency and low health literacy, complex medication histories, or impaired mental status.

-- The Preventing Venous Thromboembolisms in the Hospital and the Interactive Venous Thromboembolism Safety Toolkit for Providers and Patients toolkits focus on multidisciplinary approaches to the elimination of preventable hospital-acquired blood clots.

-- The ED Pharmacist as a Safety Measure in Emergency Medicine toolkit focuses on improving medication safety and reconciliation through the implementation of a program that places pharmacists in hospital emergency departments.

In addition, the 17 PIPS toolkits correlate with the Joint Commission's National Patient Safety Goals, which promote system wide improvements in patient safety. For more information and a complete listing of the 17 toolkits, visit http://www.ahrq.gov/qual/pips.


'/>"/>
SOURCE Agency for Healthcare Research & Quality
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Cleveland Clinic Press Releases Journal-Writing Book Write for Life: Healing Body, Mind, and Spirit Through Journal Writing by Sheppard B. Kominars, Ph.D.
2. Leading Child Abuse Center Releases Back to School Tips to Protect Children From Internet Predators
3. JHA Releases 2007 U.S. Group Disability Mid-Year Market Survey Results
4. Verdict One Releases Directory of Board Certified Attorneys for Consumers
5. Academy releases emergency preparedness tools to enable millions more people to shelter in place
6. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
7. MITEM Releases Blue Iris eLaborate 8.6
8. Produce for Better Health Foundation Releases Statement on Study Saying Fruit & Vegetable Consumption Not Strongly Associated With Colon Cancer Risk
9. Patient Safety Authority Releases Advisory Focusing on Common Causes of Medication Errors
10. URAC Releases Issue Briefs Examining Stakeholders Views of Care Coordination Along the Healthcare Continuum
11. Cardiac Science Releases New Cardiac Rehabilitation System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2008)... Telemedicine Encounter Management Systems (TEMS) ...a possible solution to national health care proble...RWEB) August 29, 2008 -- If there has been any one... Democratic National Convention it has been the pa...alth care issues., , ,Our Democratic leadership re...
(Date:8/29/2008)...aronowitzmd.com [Los Angeles cosmetic surgeon], D...stic surgery procedures for post bariatric weight ...sary for these patients, health and wellness. Dr.... of procedures for after weight loss. , ...2008 -- Bariatric surgery improves the health of m...
(Date:8/28/2008)...nal therapy, study found , , THURSDAY, A...ill improves brain function and fitness for people...sual rehabilitation program, a new study found. ,... said study researcher Dr. Andreas Luft, a profess...t the University of Zurich in Switzerland. "One is...
(Date:8/28/2008)...s of the Maryland Medicaid contract, HARRISBURG, ...ical,management firm, appointed Lenaye Lawyer, MD,...awyer will oversee all clinical aspects of Medicai...y, Maryland Harrisburg,office., "Dr. Lawyer has p...aid,Alice Stollenwerk Petrulis, MD, FACP, Chief Me...
Breaking Medicine News(10 mins):Health News:AMD Global Telemedicine Inc. Invited to Attend Democratic National Convention 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 3Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 4Health News:Treadmill Workouts Help Stroke Survivors 2Health News:Lenaye Lawyer, MD, FACOG, Named KePRO Medical Director 2
...n can predict whether a pregnant woman is at risk ...or pre-term births are women with previous pre-ter...ncy, and those who suffer from diabetes and/or hyp...her a woman will go into premature labor is the us...
...or perennial allergic rhinitis appears to be more ... 50 patients with perennial allergic rhinitis. The...f a homeopathic preparation of principal inhalent ... after the start of treatment, the group compared ...
...orn before 25 weeks' gestation often have severe n...ers report in the August 10th issue of The New Eng...entified 308 children born at the gestational age ...and. Of these, 283 were assessed for neurologic fu...
...esearhers increasing doses of painkillers to ease ...ten their lives.Some health professionals have cri...but doctors at St Christopher's Hospice in London ... of drugs such as morphine live just as long as th...
Other Medicine News:
(Date:8/28/2008)...rents to protect their 11- and 12-year-olds from,m...es cervical cancer, ATLANTA, Aug 28 /PRNewswire-U...Prevention,s (CDC) National Center for Immunizatio...w public service announcements,(PSAs) targeting th...ast,organizations. The television and radio spots,...
(Date:8/28/2008)...swire-FirstCall/ --, - Results Further Support th... Under Development to Improve the Survival of Pati...), Algeta ASA (OSE: ALGETA), the Norwegian cancer...imary objective of its BC1-03 Phase II pain,pallia...gle doses of,Alpharadin in patients with painful b...
(Date:8/27/2008)...m Makes Crucial Breakthrough in Battle to Prevent ... CHICAGO, Aug. 27 /- The British Mid... scientists at The University of Nottingham,have m...r prevent the onset,of a very common type of demen...e genetically produced the first ever mouse model,...
(Date:8/26/2008)...- The Oregon Tourism Commission,launc...ice Training Program,(Q Care) this week on http:/...ng program created to support the tourism and,hosp...on. By emphasizing,the importance of quality custo...h tools and resources to better serve Oregon,s vis...
Breaking Medicine Technology:Algeta Reports Positive Headline Phase II Data on Pain Palliation With Alpharadin 2Algeta Reports Positive Headline Phase II Data on Pain Palliation With Alpharadin 3Algeta Reports Positive Headline Phase II Data on Pain Palliation With Alpharadin 4The University of Nottingham in the British Midlands Announces Breakthrough in Parkinson's Disease Research 2Oregon Tourism Commission Unveils New Online Customer Service Training Program 2Long Term Care Insurance Leader Offers Advice on Preventing Dementia the Leading Cause of Care Claims 9944 1Long Term Care Insurance Leader Offers Advice on Preventing Dementia the Leading Cause of Care Claims 9944 2Divine Corporations Personal Lubricants Shown to Block Cancer causing Viruses in a Study by the National Cancer Institute 1246 1Divine Corporations Personal Lubricants Shown to Block Cancer causing Viruses in a Study by the National Cancer Institute 1246 2LOGICARE Selects M2SYS Biometric Fingerprint Software to Ensure Patient Privacy and Protect Confidential Information 1988 1LOGICARE Selects M2SYS Biometric Fingerprint Software to Ensure Patient Privacy and Protect Confidential Information 1988 2Ohio Prematurity Caucus Forming to Meet Challenge 9938 1Ohio Prematurity Caucus Forming to Meet Challenge 9938 2Ohio Prematurity Caucus Forming to Meet Challenge 9938 3
..., 2007 /PRNewswire/ -- Asenapine -- an,investigati...althcare business unit of Akzo Nobel, for bipolar ...o be more effective than placebo,in treating acute...I disorder, according to new Phase III results, fr...ssociation,s 2007 Annual,Meeting. , In the three-w...
...t 2007 APA Meeting -, COLLEGEVILLE, Pa., May 21, 2...tudies examining safety and efficacy of,desvenlafa...e,inhibitor (SNRI) being studied as a potential tr...(MDD), were presented today at the,2007 American P...,Calif., by Wyeth Pharmaceuticals, a division of ...
Other Medicine Technology:Organon's Asenapine Effective in a Phase III Study for the,Treatment of Bipolar I Disorder; Results Unveiled at 2007 APA,Meeting 2Organon's Asenapine Effective in a Phase III Study for the,Treatment of Bipolar I Disorder; Results Unveiled at 2007 APA,Meeting 3Organon's Asenapine Effective in a Phase III Study for the,Treatment of Bipolar I Disorder; Results Unveiled at 2007 APA,Meeting 4New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 2New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 3New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 4New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 5New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 6New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 7New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 8
Avant E-Z Rack Premium Low Binding 10 l Microreach Pipet Tips are accurate, contamination free, and allow quantitative transfer of your samples without relying on silicone.
1000 L, Racked, 96 tips/rack, clear Recommended for 500 and 1000 L pipettes.
300 L, Racked, 96 tips/rack Recommended for 250 and 300 L pipettes. Can also be used with 20, 25, 50, 100 and 200 L pipette
Application: Pipette tips in a rack for single- and multichannel systems. Product features of Autoclavable Racks: Can be steam sterilized at 121 C, Tips supplied in racks with an 8 x 12 row format,
Medicine Products: